[Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004361:Drug Tolerance; D005905:Glyburide / Q000008:administration & dosage / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D013997:Time Factors; D014508:Urea / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D014508:Urea; D005905:Glyburide
Prüfung eines neuen Antidiabetikums (Glibenclamid) bei stationären und ambulanten Diabetikern.